Clinical Approach to Easy Bruising and Bleeding
Pediatric Comprehensive Framework1. Symptom Overview
Understanding the clinical significance and classification of easy bruising and bleeding tendency in children
Easy bruising and bleeding tendency is one of the most common reasons for pediatric hematology referrals, accounting for approximately 15-20% of all consultations. While the majority of children referred for bleeding symptoms have no identifiable bleeding disorder, an estimated 1-2% of the general pediatric population has an inherited bleeding disorder. Bruising is reported in up to 12% of healthy children, making the distinction between normal childhood bruising and pathological bleeding a critical clinical skill. The challenge lies in identifying the small subset of children with serious underlying conditions while avoiding unnecessary testing in those with benign causes.
Key Epidemiology
- Von Willebrand disease: Most common inherited bleeding disorder, affecting approximately 1% of the population (though clinically significant disease affects 1 in 1,000)
- Hemophilia A (Factor VIII deficiency): 1 in 5,000 male births
- Hemophilia B (Factor IX deficiency): 1 in 30,000 male births
- Immune thrombocytopenia (ITP): 4-5 per 100,000 children per year, peak age 2-5 years
- Platelet function disorders: Estimated 1 in 10,000 to 1 in 20,000
Definition
Easy bruising refers to the appearance of bruises (ecchymoses) with minimal or no apparent trauma, or bruising that is disproportionate to the degree of injury. Bleeding tendency encompasses a broader spectrum including prolonged bleeding from minor wounds, spontaneous bleeding from mucosal surfaces, or excessive bleeding following surgical or dental procedures. These symptoms may indicate dysfunction in primary hemostasis (platelet plug formation), secondary hemostasis (coagulation cascade), fibrinolysis, or vascular integrity.
Classification by Onset and Duration
| Category | Onset Pattern | Common Causes | Clinical Significance |
|---|---|---|---|
| Congenital/Lifelong | Present since birth or early infancy; symptoms with circumcision, umbilical cord separation, or first trauma | Hemophilia A and B, severe von Willebrand disease, inherited platelet disorders, rare factor deficiencies | High likelihood of inherited bleeding disorder; requires comprehensive workup; family history often positive |
| Acute Onset | Sudden onset over days to weeks in a previously well child | Immune thrombocytopenia, acute leukemia, disseminated intravascular coagulation, drug-induced, infection-related | Requires urgent evaluation; may indicate serious underlying condition; often associated with systemic illness |
| Chronic/Recurrent | Intermittent symptoms over months to years; may be triggered by specific events | Mild von Willebrand disease, mild hemophilia, platelet function disorders, chronic immune thrombocytopenia | Often diagnosed after dental extraction or surgery; may require provocative testing for diagnosis |
| Situational | Bleeding only in specific contexts (post-surgical, post-dental, with menses) | Mild factor deficiencies, mild von Willebrand disease, platelet dysfunction | Baseline hemostatic studies may be normal; challenge testing or response to hemostatic agents aids diagnosis |
Classification by Type of Bleeding
The pattern and location of bleeding provides critical diagnostic clues, as different hemostatic defects produce characteristic bleeding manifestations.
Mucocutaneous Bleeding (Primary Hemostasis Defects)
Suggests: Platelet disorders or von Willebrand disease
- Petechiae (pinpoint, non-blanching spots)
- Superficial ecchymoses (bruises)
- Epistaxis (nosebleeds)
- Gingival bleeding
- Menorrhagia (heavy menstrual bleeding)
- Prolonged bleeding from minor cuts
- Gastrointestinal bleeding
Timing: Immediate bleeding at time of injury
Deep Tissue Bleeding (Secondary Hemostasis Defects)
Suggests: Coagulation factor deficiencies
- Hemarthrosis (joint bleeding)
- Deep muscle hematomas
- Intracranial hemorrhage
- Retroperitoneal bleeding
- Large, palpable ecchymoses
- Prolonged post-surgical bleeding
- Umbilical stump bleeding (neonates)
Timing: Delayed bleeding hours after initial hemostasis
Classification by Severity
| Severity | Clinical Features | Examples | Management Implications |
|---|---|---|---|
| Severe | Spontaneous bleeding into joints or muscles; intracranial hemorrhage; life-threatening bleeding; factor levels less than 1% | Severe hemophilia A or B; severe platelet disorders; afibrinogenemia | Requires prophylactic factor replacement; comprehensive care center management; high risk of joint disease |
| Moderate | Bleeding with minor trauma; occasional spontaneous bleeding; factor levels 1-5% | Moderate hemophilia; type 3 von Willebrand disease; moderate platelet disorders | On-demand treatment often sufficient; may need prophylaxis for high-risk activities; pre-procedural coverage essential |
| Mild | Bleeding only with significant trauma, surgery, or dental procedures; factor levels 5-40% | Mild hemophilia; type 1 von Willebrand disease; mild platelet dysfunction | May be undiagnosed until hemostatic challenge; pre-procedural assessment critical; desmopressin often effective |
Age-Specific Presentations
| Age Group | Typical Presentations | Key Considerations |
|---|---|---|
| Neonate (0-28 days) | Cephalohematoma, prolonged umbilical stump bleeding, circumcision bleeding, intracranial hemorrhage, bleeding from heel pricks | Vitamin K deficiency bleeding if prophylaxis missed; severe hemophilia often presents; maternal immune thrombocytopenia can cause neonatal thrombocytopenia |
| Infant (1-12 months) | Excessive bruising when starting to crawl/cruise, oral mucosal bleeding with teething, large hematomas from vaccinations | Distinguish from non-accidental injury; hemophilia typically diagnosed by this age; consider child abuse in unexplained bruising |
| Toddler (1-3 years) | Bruising over shins and forehead (typical locations), epistaxis, excessive bleeding from minor injuries | Peak age for immune thrombocytopenia; normal toddler bruising common over bony prominences; non-accidental injury considerations |
| School Age (4-12 years) | Epistaxis, prolonged bleeding after dental procedures, sports-related excessive bruising, heavy menstrual periods (older girls) | Mild bleeding disorders often diagnosed at this age; von Willebrand disease commonly presents; school and sports participation concerns |
| Adolescent (13-18 years) | Menorrhagia (leading cause of iron deficiency in adolescent females), post-surgical bleeding, sports injuries with excessive bleeding | Menorrhagia as first presentation of von Willebrand disease in up to 20% of cases; dental extractions (wisdom teeth) may unmask mild disorders |
Normal Versus Pathological Bruising in Children
Distinguishing normal developmental bruising from pathological bleeding is essential to avoid both missed diagnoses and unnecessary testing.
Features of Normal Childhood Bruising
- Located over bony prominences (shins, forehead, elbows, knees)
- Correlates with developmental stage (increased with walking, running)
- Small to moderate size (less than 10 mm in non-mobile infants, larger acceptable in active children)
- Proportionate to reported trauma
- No associated petechiae or mucosal bleeding
- Normal healing pattern
- Child is otherwise well and thriving
Features Suggesting Pathological Bruising
- Bruising in unusual locations (trunk, buttocks, face, neck, ears)
- Bruising in non-mobile infants (concerning for abuse or bleeding disorder)
- Multiple bruises of different ages
- Associated petechiae or purpura
- Mucosal bleeding (epistaxis, gingival, oral)
- Disproportionate to reported trauma
- Family history of bleeding disorders
- Systemic symptoms (pallor, fatigue, fever, lymphadenopathy)
Key Clinical Concept: The approach to easy bruising and bleeding in children requires integration of three critical assessments: (1) Is this bleeding truly abnormal or within the spectrum of normal childhood bruising? (2) Does the pattern suggest a primary hemostatic defect (platelet/vessel), secondary hemostatic defect (coagulation factors), or combined disorder? (3) Is the presentation consistent with inherited versus acquired disease? This framework guides both the urgency of evaluation and the choice of diagnostic testing.
Critical Reminder: Non-Accidental Injury
When evaluating a child with bruising, always consider the possibility of non-accidental injury (child abuse). Key features that should raise concern include: bruising in non-mobile infants, bruises in unusual locations (ears, neck, buttocks, trunk), patterned bruises suggesting implements, discrepant history, delay in seeking care, and multiple injuries of varying ages. A bleeding disorder evaluation should be performed when clinically indicated, but this should not delay child protection assessment when abuse is suspected. Conditions such as immune thrombocytopenia and bleeding disorders can coexist with abuse.
2. Pathophysiology and Mechanisms
Understanding the hemostatic system and mechanisms of bleeding in children
Normal hemostasis is a carefully balanced process that prevents both excessive bleeding and inappropriate thrombosis. Understanding the components of this system is essential for interpreting bleeding symptoms and laboratory findings. In children, developmental changes in the hemostatic system add another layer of complexity, as normal values for many coagulation parameters differ significantly from adults, particularly in neonates and young infants.
Overview of Normal Hemostasis
Hemostasis occurs in three overlapping phases that work in concert to achieve stable clot formation and subsequent wound healing.
| Phase | Key Components | Process | Clinical Correlate |
|---|---|---|---|
| Primary Hemostasis | Vascular endothelium, platelets, von Willebrand factor | Vasoconstriction → platelet adhesion → platelet activation → platelet aggregation → formation of primary platelet plug | Defects cause mucocutaneous bleeding (petechiae, epistaxis, gingival bleeding); immediate bleeding at time of injury |
| Secondary Hemostasis | Coagulation factors (intrinsic, extrinsic, common pathways), tissue factor, calcium, phospholipid surfaces | Coagulation cascade activation → thrombin generation → fibrin formation → stabilization of platelet plug | Defects cause deep tissue bleeding (hemarthrosis, muscle hematomas); delayed bleeding hours after initial hemostasis |
| Fibrinolysis | Plasminogen, tissue plasminogen activator, plasmin, alpha-2-antiplasmin, plasminogen activator inhibitor | Controlled clot dissolution → wound remodeling → vessel recanalization | Defects in regulation cause delayed bleeding, re-bleeding after initial hemostasis, or poor wound healing |
Primary Hemostasis: Platelet Plug Formation
| Step | Process | Key Mediators | Clinical Relevance |
|---|---|---|---|
| 1. Vasoconstriction | Immediate vessel narrowing to reduce blood flow | Endothelin, thromboxane A2, serotonin, neural reflexes | Impaired in connective tissue disorders (Ehlers-Danlos syndrome); accounts for initial bleeding control |
| 2. Platelet Adhesion | Platelets attach to exposed subendothelial collagen | Von Willebrand factor (bridge between collagen and platelet GPIb receptor), collagen receptors (GPIa/IIa, GPVI) | Defective in von Willebrand disease (reduced or dysfunctional von Willebrand factor) and Bernard-Soulier syndrome (absent GPIb) |
| 3. Platelet Activation | Shape change, granule release, surface receptor expression | ADP, thromboxane A2, thrombin, collagen; intracellular signaling pathways | Impaired in storage pool disorders (reduced granule contents) and signal transduction defects; aspirin inhibits thromboxane synthesis |
| 4. Platelet Aggregation | Platelets bind to each other forming primary plug | Fibrinogen bridges between GPIIb/IIIa receptors on adjacent platelets | Defective in Glanzmann thrombasthenia (absent GPIIb/IIIa); blocked by GPIIb/IIIa inhibitor drugs |
Secondary Hemostasis: Coagulation Cascade
The coagulation cascade is a series of enzymatic reactions that culminates in thrombin generation and fibrin clot formation. The modern cell-based model recognizes three overlapping phases.
Initiation Phase
Location: Tissue factor-bearing cells
Process: Tissue factor exposed by vessel injury binds Factor VIIa → activates Factor X and Factor IX → small amount of thrombin generated
Clinical relevance: Factor VII deficiency causes variable bleeding; measured by prothrombin time (PT)
Amplification Phase
Location: Platelet surface
Process: Small amounts of thrombin activate platelets → activate Factors V, VIII, and XI on platelet surface → prepares for burst of thrombin generation
Clinical relevance: Factor VIII and IX deficiencies (hemophilia A and B) cause severe bleeding due to impaired amplification
Propagation Phase
Location: Activated platelet surface
Process: Factor IXa-VIIIa complex (tenase) activates Factor X → Factor Xa-Va complex (prothrombinase) generates large amounts of thrombin → thrombin converts fibrinogen to fibrin
Clinical relevance: This “thrombin burst” is essential for stable clot; Factor XIII crosslinks fibrin for clot stability
Key Coagulation Factors and Their Deficiencies
| Factor | Function | Deficiency State | Inheritance and Prevalence | Laboratory Finding |
|---|---|---|---|---|
| Factor VIII | Cofactor for Factor IXa in tenase complex | Hemophilia A | X-linked recessive; 1 in 5,000 males | Prolonged activated partial thromboplastin time (aPTT); normal PT |
| Factor IX | Serine protease in tenase complex | Hemophilia B (Christmas disease) | X-linked recessive; 1 in 30,000 males | Prolonged aPTT; normal PT |
| Von Willebrand Factor | Platelet adhesion; Factor VIII carrier | Von Willebrand disease (types 1, 2, 3) | Autosomal dominant (types 1, 2) or recessive (type 3); 1% prevalence | May have prolonged aPTT; prolonged bleeding time; low von Willebrand factor antigen and activity |
| Factor XI | Activates Factor IX; amplification | Hemophilia C | Autosomal recessive; common in Ashkenazi Jewish population | Prolonged aPTT; bleeding severity does not correlate with factor level |
| Factor VII | Initiates extrinsic pathway with tissue factor | Factor VII deficiency | Autosomal recessive; 1 in 500,000 | Prolonged PT; normal aPTT |
| Fibrinogen (Factor I) | Converted to fibrin; final common pathway | Afibrinogenemia, hypofibrinogenemia, dysfibrinogenemia | Autosomal recessive; 1 in 1,000,000 | Prolonged PT, aPTT, and thrombin time; low or absent fibrinogen |
| Factor XIII | Crosslinks fibrin for clot stability | Factor XIII deficiency | Autosomal recessive; 1 in 2,000,000 | Normal PT and aPTT; specific Factor XIII assay required |
Mechanisms of Bleeding by Condition Category
Platelet Disorders
| Condition | Mechanism | Key Features | Treatment Implications |
|---|---|---|---|
| Immune Thrombocytopenia (ITP) | Autoantibodies against platelet glycoproteins (usually GPIIb/IIIa or GPIb/IX) → splenic destruction and impaired production | Acute onset in previously well child, often post-viral; isolated thrombocytopenia with otherwise normal blood counts; typically self-limiting in children | Observation for mild cases; corticosteroids, intravenous immunoglobulin, or anti-D immunoglobulin for significant bleeding or very low counts |
| Bernard-Soulier Syndrome | Absent or dysfunctional GPIb-IX-V complex → impaired platelet adhesion to von Willebrand factor | Large platelets on blood smear; moderate to severe mucocutaneous bleeding; may have mild thrombocytopenia | Platelet transfusion for significant bleeding; desmopressin ineffective; avoid antiplatelet agents |
| Glanzmann Thrombasthenia | Absent or dysfunctional GPIIb/IIIa → impaired platelet aggregation despite normal adhesion | Normal platelet count and size; absent aggregation to all agonists except ristocetin; severe mucocutaneous bleeding from infancy | Platelet transfusion; recombinant Factor VIIa for refractory bleeding or alloimmunization |
| Storage Pool Disorders | Deficiency of dense granules (delta storage pool deficiency) or alpha granules (gray platelet syndrome) → impaired platelet activation and secondary aggregation | Mild to moderate bleeding; may be associated with syndromic features (Hermansky-Pudlak, Chediak-Higashi) | Desmopressin may be effective; platelet transfusion for significant bleeding |
Coagulation Factor Disorders
| Condition | Mechanism | Key Features | Treatment Implications |
|---|---|---|---|
| Hemophilia A | Absent or reduced Factor VIII → impaired thrombin generation in amplification phase → unstable clot formation | X-linked; spontaneous hemarthrosis and deep muscle bleeds in severe disease; delayed post-surgical bleeding; target joint development if untreated | Factor VIII replacement (prophylaxis or on-demand); desmopressin for mild hemophilia; emicizumab for prophylaxis |
| Hemophilia B | Absent or reduced Factor IX → impaired tenase complex formation → reduced thrombin generation | Clinically indistinguishable from hemophilia A; X-linked; same bleeding pattern | Factor IX replacement; desmopressin not effective; gene therapy emerging |
| Von Willebrand Disease | Type 1: Reduced quantity of von Willebrand factor Type 2: Qualitative defect Type 3: Complete absence | Mucocutaneous bleeding predominates; secondary reduction in Factor VIII in severe cases can cause joint bleeding; variable severity | Desmopressin for type 1 (releases stored von Willebrand factor); von Willebrand factor concentrates for types 2 and 3; antifibrinolytics as adjunct |
| Vitamin K Deficiency | Reduced synthesis of vitamin K-dependent factors (II, VII, IX, X) and anticoagulant proteins (protein C, protein S) → global coagulopathy | Neonates at highest risk (vitamin K deficiency bleeding); also seen in malabsorption, liver disease, warfarin therapy, antibiotic use | Vitamin K replacement (oral or parenteral); fresh frozen plasma for acute severe bleeding |
Developmental Hemostasis in Children
The hemostatic system undergoes significant maturation from birth through childhood. Understanding these developmental differences is essential for interpreting laboratory tests and recognizing age-specific bleeding risks.
| Age Group | Key Differences from Adults | Clinical Implications |
|---|---|---|
| Preterm Neonates | Further reduced coagulation factors compared to term neonates; lower platelet counts acceptable (greater than 100,000/microL normal); reduced von Willebrand factor | Higher bleeding risk, especially intracranial hemorrhage; very sensitive to vitamin K deficiency; require gestational age-specific reference ranges |
| Term Neonates (0-28 days) | Vitamin K-dependent factors 30-50% of adult levels; Factor VIII and von Willebrand factor at adult levels or higher; protein C and S very low; aPTT physiologically prolonged | Normal PT excludes vitamin K deficiency; prolonged aPTT may be normal; thrombosis rare but can occur; hemophilia can be diagnosed at birth |
| Infants (1-12 months) | Gradual increase in vitamin K-dependent factors; most factors reach adult levels by 6 months; Factor IX may remain low | Laboratory results approach adult values; still require age-appropriate reference ranges; hemophilia typically clinically apparent |
| Children (greater than 1 year) | Coagulation factor levels similar to adults; von Willebrand factor continues to increase through childhood | Adult reference ranges generally applicable; von Willebrand disease may be more apparent in young children due to lower von Willebrand factor levels |
Often Overlooked Mechanism: Factor XIII Deficiency
Factor XIII deficiency is one of the most commonly missed severe bleeding disorders because standard coagulation tests (PT and aPTT) are completely normal. Factor XIII crosslinks fibrin polymers to form a stable clot; without it, clots form but dissolve prematurely. The classic presentation is umbilical stump bleeding (occurs in approximately 80% of affected neonates), delayed bleeding after circumcision, intracranial hemorrhage in infancy, and poor wound healing. Always consider Factor XIII deficiency when there is a strong bleeding history with normal routine coagulation tests, and order a specific Factor XIII activity assay.
Understanding the Pattern: Why Location Matters
The distinction between mucocutaneous and deep tissue bleeding reflects the underlying physiology. Primary hemostasis (platelets and von Willebrand factor) is sufficient to control bleeding in areas with high tissue pressure that can compress vessels and support the fragile primary platelet plug (such as skin and mucous membranes). However, in areas with low tissue pressure (joints, muscles, deep tissues), the secondary fibrin clot is essential to maintain hemostasis. This explains why patients with platelet disorders develop petechiae and epistaxis (high-pressure areas adequately controlled by primary hemostasis elsewhere), while patients with hemophilia develop hemarthrosis and deep hematomas (low-pressure areas requiring fibrin stabilization).
Pathophysiology of Acquired Bleeding Disorders in Children
| Condition | Mechanism | Laboratory Pattern | Key Features |
|---|---|---|---|
| Disseminated Intravascular Coagulation | Systemic activation of coagulation → consumption of platelets and factors → secondary fibrinolysis → combined thrombosis and bleeding | Prolonged PT and aPTT; low fibrinogen; elevated D-dimer; thrombocytopenia; schistocytes on smear | Always secondary to underlying condition (sepsis, malignancy, trauma); treat underlying cause; supportive blood product replacement |
| Liver Disease | Reduced synthesis of clotting factors (all except Factor VIII and von Willebrand factor); reduced thrombopoietin; portal hypertension with splenic sequestration | Prolonged PT greater than aPTT; may have thrombocytopenia; normal or elevated Factor VIII | Complex hemostatic derangement; both bleeding and thrombosis risk; vitamin K trial may help if cholestasis present |
| Renal Disease | Uremic platelet dysfunction (abnormal adhesion and aggregation due to uremic toxins); anemia reduces platelet-vessel wall interaction | Normal platelet count; prolonged bleeding time; normal PT and aPTT; abnormal platelet function testing | Improves with dialysis; desmopressin may help acutely; correction of anemia improves hemostasis |
| Acute Leukemia | Bone marrow infiltration → thrombocytopenia; disseminated intravascular coagulation (especially acute promyelocytic leukemia); leukemic cells may produce procoagulant or fibrinolytic factors | Thrombocytopenia; may have abnormal PT/aPTT if disseminated intravascular coagulation present; blast cells on smear | Bleeding may be presenting symptom; look for additional cytopenias, lymphadenopathy, hepatosplenomegaly |
Integration: From Mechanism to Clinical Presentation
Understanding the pathophysiology of hemostasis allows prediction of clinical features:
- Platelet disorders and von Willebrand disease: Immediate bleeding, mucocutaneous pattern, petechiae suggest platelet-vessel interaction problem
- Coagulation factor deficiencies: Delayed bleeding, deep tissue pattern, hemarthrosis suggest fibrin clot stabilization problem
- Combined defects: Both patterns may be present (severe von Willebrand disease with low Factor VIII, disseminated intravascular coagulation, liver failure)
- Fibrinolytic disorders: Delayed re-bleeding after initial hemostasis, poor wound healing
3. History Taking
A comprehensive approach to eliciting the bleeding history in children
Red Flags — Require Urgent Evaluation
- Intracranial hemorrhage — life-threatening; may indicate severe bleeding disorder
- Severe anemia with active bleeding — hemodynamic compromise risk
- Widespread petechiae with fever — sepsis, meningococcemia, leukemia
- Platelet count less than 10,000/microL — high risk of spontaneous bleeding
- Rapidly enlarging hematoma — compartment syndrome risk
- Hemarthrosis with joint swelling — suggests severe factor deficiency
- Umbilical stump bleeding in neonate — Factor XIII deficiency, severe hemophilia
- Prolonged bleeding after circumcision — inherited bleeding disorder
- New bruising in non-mobile infant — bleeding disorder or non-accidental injury
- Pallor, fatigue, lymphadenopathy with bruising — leukemia, aplastic anemia
- Hepatosplenomegaly with bleeding — malignancy, liver disease, storage disorders
- Melena or hematemesis — significant gastrointestinal bleeding
Systematic History: The “BLEEDS” Approach
Use the mnemonic “BLEEDS” to ensure comprehensive bleeding history in children:
- B — Bruising and Bleeding sites: Where does the child bleed? Skin, mucous membranes, joints, muscles? Pattern suggests underlying defect.
- L — Lifespan of symptoms: When did bleeding first occur? Present since birth (congenital) or new onset (acquired)? Triggered by specific events?
- E — Episodes and severity: How many bleeding episodes? Did they require medical attention, transfusion, or hospitalization? Quantify menstrual bleeding.
- E — Exposures and challenges: How did the child respond to hemostatic challenges? Surgery, dental extractions, trauma, circumcision, vaccinations?
- D — Drugs and diseases: Medications (especially NSAIDs, aspirin, anticoagulants)? Underlying conditions (liver disease, renal disease, malignancy)?
- S — Kin and bloodline: Family history of bleeding? Consanguinity? Ethnicity (some disorders more common in specific populations)?
Quantifying Bleeding: The Pediatric Bleeding Score
Standardized bleeding assessment tools help distinguish pathological from normal bleeding. A positive bleeding score increases the likelihood of a bleeding disorder.
| Symptom | Score 0 (None/Trivial) | Score 1 (Mild) | Score 2 (Moderate) | Score 3-4 (Severe) |
|---|---|---|---|---|
| Epistaxis | None or fewer than 5 episodes | More than 5 episodes or lasting more than 10 minutes | Consultation required or cauterization | Transfusion, replacement therapy, or desmopressin needed |
| Bruising | None or fewer than 5 bruises with trauma | More than 5 bruises larger than 1 cm, no trauma | Consultation required | Spontaneous hematomas requiring treatment |
| Bleeding from minor wounds | None or fewer than 5 episodes | More than 5 episodes or lasting more than 10 minutes | Consultation required | Surgical hemostasis or transfusion needed |
| Oral cavity bleeding | None | Present but not requiring attention | Consultation required | Transfusion, replacement therapy, or desmopressin needed |
| Dental extraction bleeding | None or no extractions performed | Reported, no intervention | Repacking or cauterization | Transfusion or re-operation required |
| Surgical bleeding | None or no surgeries performed | Reported, no intervention | Surgical hemostasis or extended stay | Transfusion or re-operation required |
| Menorrhagia | None | Consultation only | Antifibrinolytics, hormonal therapy | Transfusion, replacement therapy, hysterectomy |
| Muscle hematomas | Never | Post-trauma, no treatment | Spontaneous, no treatment | Spontaneous or traumatic requiring treatment |
| Hemarthrosis | Never | Post-trauma, no treatment | Spontaneous, no treatment | Spontaneous or traumatic requiring treatment |
Interpreting the Bleeding Score
Total score interpretation: A score of 3 or higher in children suggests an increased likelihood of bleeding disorder and warrants laboratory investigation. The higher the score, the greater the probability of identifying an underlying disorder. However, a low score does not exclude mild bleeding disorders, particularly in young children who may not have experienced sufficient hemostatic challenges.
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Immune thrombocytopenia | Acute onset petechiae and bruising in well child, often post-viral | “Did your child have a viral illness in the past 1-4 weeks? Was the child completely healthy before the bruising started?” |
| Von Willebrand disease | Mucocutaneous bleeding, menorrhagia, family history | “Does your child have frequent nosebleeds that are hard to stop? For girls: Are periods very heavy, lasting more than 7 days or soaking through pads hourly?” |
| Hemophilia | Deep tissue bleeding, hemarthrosis, X-linked inheritance | “Has your child ever had swelling and pain in joints without significant injury? Any male relatives with bleeding problems?” |
| Platelet function disorder | Mucocutaneous bleeding despite normal platelet count | “Does your child bruise easily and have prolonged bleeding from cuts, even though blood counts have been normal?” |
| Factor XIII deficiency | Delayed bleeding, umbilical stump bleeding, poor wound healing | “Did your baby have bleeding from the umbilical cord stump? Do wounds seem to heal poorly or reopen after initially stopping bleeding?” |
| Vitamin K deficiency | Neonate without prophylaxis, malabsorption, prolonged antibiotics | “Did your baby receive a vitamin K injection at birth? Does your child have any problems absorbing food or chronic diarrhea?” |
| Leukemia or bone marrow failure | Bruising with pallor, fatigue, infections, hepatosplenomegaly | “Has your child been more tired than usual? Any fevers, bone pain, or weight loss? Have you noticed any lumps or swellings?” |
| Drug-induced bleeding | Temporal relationship to medication | “Has your child taken any medications recently, including ibuprofen, aspirin, or any over-the-counter medicines? Any herbal supplements?” |
| Non-accidental injury | Unusual bruise locations, inconsistent history, developmental concerns | “Can you tell me exactly how and when each bruise occurred? Who was with the child at the time?” (Note: assess for inconsistencies and safeguarding concerns) |
| Connective tissue disorder | Easy bruising with hypermobility, skin fragility | “Is your child very flexible or ‘double-jointed’? Does the skin seem thin, stretchy, or does it scar easily?” |
Age-Specific History Components
Neonatal and Early Infancy History
| History Component | Specific Questions | Clinical Relevance |
|---|---|---|
| Birth history | Gestational age, birth weight, mode of delivery, instrumentation used, any birth trauma | Cephalohematoma or intracranial hemorrhage with vacuum/forceps may unmask bleeding disorder; prematurity affects baseline coagulation |
| Vitamin K prophylaxis | Was vitamin K given at birth? Route (intramuscular versus oral)? If oral, were follow-up doses given? | Vitamin K deficiency bleeding can present up to 6 months with oral dosing; intramuscular preferred |
| Umbilical cord | Any bleeding from umbilical stump? When did cord separate? Any oozing after separation? | Umbilical bleeding classic for Factor XIII deficiency; delayed separation may indicate leukocyte adhesion defect |
| Circumcision | Was circumcision performed? Any prolonged bleeding? Need for sutures or intervention? | Excessive circumcision bleeding is a classic presentation of hemophilia |
| Heel prick tests | Any prolonged bleeding from newborn screening blood tests? | Prolonged bleeding from minor procedures suggests bleeding disorder |
| Feeding | Breast or formula fed? Any blood in vomit or stool? Feeding difficulties? | Exclusively breastfed infants at higher risk of vitamin K deficiency; swallowed maternal blood can mimic gastrointestinal bleeding |
Developmental and Immunization History
Developmental Milestones
- Mobility onset: When did child start crawling, cruising, walking? Bruising typically increases with mobility
- Bruise correlation: Do bruises correlate with developmental stage? Shin bruises in new walkers are normal
- Activity level: Is the child appropriately active? Decreased activity may indicate joint bleeding or anemia
- Developmental regression: Any loss of skills? May indicate intracranial bleeding
Immunization History
- Vaccination response: Any excessive bruising or hematomas at injection sites?
- Intramuscular injections: Any prolonged bleeding or large hematomas after vaccines?
- Route considerations: Children with known bleeding disorders may need subcutaneous vaccination with pressure
- Recent vaccinations: Live vaccines can precede immune thrombocytopenia (especially measles, mumps, rubella)
Menstrual History (Adolescent Females)
Quantifying Menorrhagia
Heavy menstrual bleeding is the presenting symptom in up to 20% of adolescents with von Willebrand disease. Systematic assessment is essential:
- Duration: Periods lasting more than 7 days suggest menorrhagia
- Frequency of pad/tampon changes: Changing more frequently than every 2 hours suggests heavy bleeding
- Clot passage: Clots larger than a 10 pence coin or quarter suggest heavy bleeding
- Night-time soaking: Need to change pads overnight or soiling bedclothes is abnormal
- Impact on activities: Missing school or activities due to periods indicates significant bleeding
- Iron deficiency: Low ferritin or iron deficiency anemia secondary to menstrual loss
- Use of menstrual aids: Need for “double protection” (pad and tampon together) suggests heavy bleeding
Medication and Social History
Medications That Cause or Worsen Bleeding
- Non-steroidal anti-inflammatory drugs (NSAIDs): Ibuprofen, naproxen — inhibit platelet cyclooxygenase
- Aspirin: Irreversible platelet inhibition; effect lasts platelet lifespan (7-10 days)
- Valproic acid: Can cause thrombocytopenia and platelet dysfunction
- Antibiotics (prolonged): Reduce vitamin K-producing gut flora
- Chemotherapy: Bone marrow suppression causing thrombocytopenia
- Anticoagulants: Warfarin, heparin, direct oral anticoagulants
- Selective serotonin reuptake inhibitors: Impair platelet serotonin uptake and function
- Herbal supplements: Ginkgo, garlic, ginger, fish oil can impair platelet function
Social and Environmental History
- Diet: Vitamin K-rich foods? Restrictive diets? Malnutrition risk?
- Activity level: Sports participation? Contact sports? Level of supervision?
- School attendance: Missed school due to bleeding episodes?
- Household safety: Any concerns about home environment?
- Psychosocial factors: Anxiety about bleeding? Impact on quality of life?
- Travel history: Dengue and other hemorrhagic fevers endemic areas
- Exposure history: Recent viral illnesses (may trigger immune thrombocytopenia)
- Tick exposure: Ehrlichiosis, Rocky Mountain spotted fever can cause thrombocytopenia
Family History: Essential Component
| Family History Finding | Suggested Inheritance Pattern | Conditions to Consider |
|---|---|---|
| Affected males on maternal side | X-linked recessive | Hemophilia A, Hemophilia B, Wiskott-Aldrich syndrome |
| Affected individuals in multiple generations | Autosomal dominant | Von Willebrand disease (types 1 and 2), Factor XI deficiency (variable), some platelet disorders |
| Consanguineous parents with affected child | Autosomal recessive | Glanzmann thrombasthenia, Bernard-Soulier syndrome, rare factor deficiencies, type 3 von Willebrand disease |
| Ashkenazi Jewish ancestry | Higher prevalence of specific disorders | Factor XI deficiency (Hemophilia C), Gaucher disease |
| No family history | New mutation, recessive carrier state, acquired condition, or non-penetrant carrier | Up to 30% of hemophilia cases are new mutations; immune thrombocytopenia is acquired |
| Family history of early death from bleeding | Severe bleeding disorder | Severe hemophilia, severe von Willebrand disease, severe platelet disorders (historical, pre-treatment era) |
Clinical Pearl: Taking a Family Bleeding History
When taking family history, ask specifically about bleeding symptoms rather than diagnosed disorders, as many family members may be undiagnosed. Useful questions include: “Has anyone in the family had problems with bleeding after surgery or dental work?” “Do any female relatives have very heavy periods?” “Has anyone needed blood transfusions for bleeding?” “Are there any relatives who bruise very easily?” Draw a three-generation pedigree when a bleeding disorder is suspected.
4. Physical Examination
A systematic head-to-toe approach for easy bruising and bleeding tendency in children
Systematic Framework: Use the “Head to Extremities” approach for complete examination of children presenting with easy bruising or bleeding tendency. Pay particular attention to the pattern, distribution, and characteristics of skin findings, as these provide critical diagnostic clues.
General Inspection
- Overall appearance: Well or unwell? Active and playful or lethargic? Pallor suggesting anemia from blood loss?
- Nutritional status: Signs of malnutrition (may indicate malabsorption with vitamin K deficiency)? Obesity (may mask deep hematomas)?
- Dysmorphic features: May suggest syndromic causes (Wiskott-Aldrich, Hermansky-Pudlak, Chediak-Higashi)
- Skin color: Pallor (anemia), jaundice (liver disease, hemolysis), cyanosis (poor perfusion)
- Growth: Failure to thrive may indicate chronic disease or malignancy
- Level of activity: Reluctance to move limbs may indicate painful hemarthrosis or muscle hematoma
- Apparent distress: Pain from bleeding complications? Respiratory distress?
Vital Signs
| Age | Heart Rate (beats/min) | Respiratory Rate (/min) | Systolic Blood Pressure (mmHg) | Clinical Significance in Bleeding |
|---|---|---|---|---|
| Neonate (0-28 days) | 100-160 | 30-60 | 60-90 | Tachycardia and hypotension are late signs of hemorrhage in neonates |
| Infant (1-12 months) | 100-150 | 25-40 | 80-100 | Pallor may be only early sign; assess capillary refill |
| Toddler (1-3 years) | 90-140 | 20-30 | 90-105 | Irritability may indicate significant blood loss before vital sign changes |
| School age (4-12 years) | 70-120 | 18-25 | 95-110 | Can maintain blood pressure until 25-30% blood volume lost |
| Adolescent (13-18 years) | 60-100 | 12-20 | 100-120 | Orthostatic changes may indicate significant blood loss |
Vital Sign Alert
Children compensate for blood loss remarkably well and may maintain normal blood pressure until they have lost 25-30% of their blood volume. Tachycardia is often the first sign of significant hemorrhage. Do not be falsely reassured by normal blood pressure in a child with ongoing bleeding. Other early signs include prolonged capillary refill (greater than 2 seconds), cool extremities, and decreased urine output.
Skin Examination: The Most Critical Component
A thorough skin examination is essential. Undress the child completely (with appropriate chaperone and consent) to visualize all skin surfaces.
Types of Skin Bleeding Lesions
| Lesion Type | Size | Description | Clinical Significance |
|---|---|---|---|
| Petechiae | Less than 2 mm | Pinpoint, non-blanching red-purple spots; do not fade with pressure | Classic for thrombocytopenia or platelet dysfunction; also seen in vasculitis, sepsis |
| Purpura | 2 mm to 1 cm | Non-blanching purple lesions; larger than petechiae | May be palpable (vasculitis) or flat (thrombocytopenia); distribution important |
| Ecchymosis (bruise) | Greater than 1 cm | Larger area of extravasated blood; color changes with age | Location and size relative to history crucial; deep tissue bleeding suggests factor deficiency |
| Hematoma | Variable | Palpable, raised collection of blood; may be fluctuant | Suggests more significant bleeding; assess for expansion; consider compartment syndrome |
Distribution of Bruising: Location Matters
Normal Childhood Bruising Locations
- Shins (anterior tibial area)
- Forehead
- Knees
- Elbows
- Bony prominences generally
These locations correspond to areas frequently impacted during normal childhood activities and play.
Concerning Bruising Locations
- Trunk, chest, back, abdomen
- Buttocks, genitalia
- Face (especially cheeks, ears, neck)
- Upper arms (grip marks)
- Any bruising in non-mobile infants
These locations should raise concern for non-accidental injury OR suggest a more severe bleeding disorder.
Bruise Aging: A Guide (Approximate)
| Color | Approximate Age | Notes |
|---|---|---|
| Red, swollen | Immediate to hours | Fresh injury |
| Blue, purple, dark | Hours to 2 days | Deoxygenated hemoglobin |
| Green | 2-7 days | Biliverdin formation |
| Yellow, brown | 7-14 days | Bilirubin and hemosiderin |
| Resolution | 2-4 weeks | Complete resorption |
Important Caveat About Bruise Dating
Bruise aging is imprecise and affected by many factors including skin color, depth of injury, location, and individual variation. Multiple colors can be present in a single bruise. Bruise color should not be used to precisely date injuries, but the presence of bruises at clearly different stages of healing should raise concern for repeated injuries over time.
Head, Eyes, Ears, Nose, and Throat Examination
Eyes
- Conjunctival pallor: Suggests anemia from chronic blood loss
- Scleral icterus: Suggests liver disease or hemolysis
- Subconjunctival hemorrhage: May indicate bleeding tendency
- Retinal hemorrhages: Concerning for intracranial hemorrhage or non-accidental injury (requires fundoscopy)
- Periorbital ecchymosis: “Raccoon eyes” — may indicate skull base fracture
Ears, Nose, and Oropharynx
- Ear bruising: Highly concerning for non-accidental injury
- Nasal examination: Active bleeding? Visible vessels? Crusting? Signs of repeated epistaxis?
- Oropharynx: Gingival bleeding, petechiae on palate, mucosal bleeding, blood-tinged saliva
- Gum hypertrophy: May suggest leukemia
- Tonsillar or pharyngeal petechiae: May indicate thrombocytopenia
Neck Examination
- Lymphadenopathy: Generalized lymphadenopathy suggests leukemia, lymphoma, or viral infection
- Cervical bruising: Highly concerning for non-accidental injury (strangulation)
- Thyroid: Thyroid disease rarely associated with bleeding but worth noting
Cardiovascular Examination
- Heart rate and rhythm: Tachycardia may indicate blood loss
- Murmurs: Flow murmur may be present with anemia
- Capillary refill: Prolonged (greater than 2 seconds) suggests poor perfusion
- Peripheral pulses: Weak pulses indicate hemodynamic compromise
Abdominal Examination
| Finding | Description | Clinical Significance |
|---|---|---|
| Hepatomegaly | Liver palpable below costal margin; note span, texture, tenderness | Leukemia, lymphoma, storage disorders, liver disease, congestive heart failure |
| Splenomegaly | Spleen palpable below costal margin; measure distance | Leukemia, lymphoma, portal hypertension, hemolytic anemia, storage disorders, infection |
| Hepatosplenomegaly | Both organs enlarged | High suspicion for hematologic malignancy or infiltrative disorder |
| Abdominal wall bruising | Ecchymoses on trunk | Concerning location; consider non-accidental injury or severe bleeding disorder |
| Abdominal distension | Increased girth, tympany or dullness | May indicate intra-abdominal hemorrhage (retroperitoneal bleed, splenic rupture) |
Musculoskeletal Examination
This is particularly important for identifying hemarthrosis and muscle hematomas, which are characteristic of coagulation factor deficiencies.
Joint Examination
| Joint Finding | Description | Clinical Significance |
|---|---|---|
| Acute hemarthrosis | Warm, swollen, painful joint; reduced range of motion; child holds joint in position of comfort (usually flexion) | Classic for moderate to severe hemophilia; most commonly affects knees, elbows, ankles |
| Chronic arthropathy (target joint) | Joint with recurrent bleeds; may have chronic swelling, muscle wasting, fixed flexion deformity, crepitus | Indicates inadequately treated hemophilia; irreversible damage |
| Hypermobility | Excessive joint range of motion; assess using Beighton score | Suggests connective tissue disorder (Ehlers-Danlos syndrome) as cause of easy bruising |
Muscle Examination
- Deep muscle hematomas: Palpable, firm, tender swelling within muscle belly; may not be visible superficially
- Iliopsoas hematoma: Hip held in flexion; pain with hip extension; abdominal or groin pain — can be life-threatening
- Forearm hematoma: Assess for compartment syndrome — pain with passive extension, tense swelling
- Calf hematoma: May mimic deep vein thrombosis; can cause compartment syndrome
Compartment Syndrome Warning Signs
Compartment syndrome is a surgical emergency. The “5 Ps” are Pain (especially pain out of proportion to injury and pain with passive stretch), Pressure (tense, firm compartment), Paresthesia (numbness or tingling), Pallor, and Pulselessness (late sign). In children with bleeding disorders, compartment syndrome can develop in the forearm or calf following relatively minor trauma. Maintain a high index of suspicion and seek urgent surgical consultation if suspected.
Neurological Examination
- Level of consciousness: Altered consciousness may indicate intracranial hemorrhage
- Fontanelle (infants): Bulging fontanelle suggests raised intracranial pressure
- Head circumference: Rapidly increasing head circumference may indicate subdural hematoma
- Focal neurological signs: May indicate intracranial bleeding
- Irritability: Non-specific but may be only sign of intracranial hemorrhage in infants
Special Examinations
Connective Tissue Assessment (Beighton Score for Hypermobility)
| Maneuver | Points (1 per side, 1 for spine) |
|---|---|
| Passive dorsiflexion of 5th metacarpophalangeal joint beyond 90 degrees | 1 point each side (maximum 2) |
| Passive apposition of thumb to flexor aspect of forearm | 1 point each side (maximum 2) |
| Hyperextension of elbow beyond 10 degrees | 1 point each side (maximum 2) |
| Hyperextension of knee beyond 10 degrees | 1 point each side (maximum 2) |
| Forward flexion of trunk with knees extended, palms flat on floor | 1 point (maximum 1) |
| Total | Maximum 9 points; score of 6 or more suggests hypermobility |
Additional Connective Tissue Features to Assess
- Skin hyperextensibility: Skin stretches more than 1.5 cm at the forearm
- Skin fragility: Thin, translucent skin; visible veins; easy tearing
- Atrophic scarring: “Cigarette paper” scars; widened scars
- Molluscoid pseudotumors: Fleshy lesions over pressure points
Expected Findings by Etiology
| Condition | Skin Findings | Musculoskeletal | Other Key Findings |
|---|---|---|---|
| Immune thrombocytopenia | Petechiae, purpura, ecchymoses; often widespread | Usually normal; no hemarthrosis | Child otherwise well; NO hepatosplenomegaly (spleen may be slightly enlarged); NO lymphadenopathy |
| Hemophilia | Large ecchymoses, palpable hematomas | Hemarthrosis (knee, elbow, ankle); muscle hematomas; chronic arthropathy in poorly controlled cases | No petechiae; examination may be normal between bleeding episodes |
| Von Willebrand disease | Ecchymoses, mucosal bleeding | Usually normal; severe forms may have hemarthrosis | Evidence of epistaxis, gingival bleeding; examination often normal |
| Leukemia | Petechiae, purpura, ecchymoses | Bone pain on palpation; limp or refusal to walk | Pallor, hepatosplenomegaly, lymphadenopathy, fever, fatigue |
| Platelet function disorder | Petechiae, ecchymoses, mucosal bleeding | Usually normal | May have syndromic features (albinism in Hermansky-Pudlak, eczema in Wiskott-Aldrich) |
| Ehlers-Danlos syndrome | Easy bruising, thin skin, atrophic scars | Joint hypermobility, dislocations | Skin hyperextensibility, abnormal wound healing, positive Beighton score |
| Henoch-Schönlein purpura | Palpable purpura on buttocks and lower extremities; symmetric distribution | Arthritis or arthralgia, often affecting ankles and knees | Abdominal pain, possible intussusception, hematuria; normal platelet count |
| Non-accidental injury | Bruises in unusual locations, patterned bruises, multiple bruises at different stages | May have fractures at different stages of healing | Inconsistent history, delayed presentation, inappropriate caregiver behavior |
Important Teaching Point
Normal examination is common! Many children with bleeding disorders, particularly mild to moderate von Willebrand disease and mild hemophilia, will have completely normal physical examinations between bleeding episodes. A normal examination does not exclude a significant bleeding disorder. The history remains the most important component of the evaluation. Similarly, immune thrombocytopenia in a child who is not actively bleeding may present with only scattered petechiae and an otherwise well-appearing child.
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways for pediatric bleeding evaluation
Step 1: Is This Urgent?
The first priority is to identify children who require immediate intervention or urgent evaluation.
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Active life-threatening hemorrhage (intracranial, gastrointestinal, airway) | EMERGENT | Resuscitate; urgent hematology consultation; give empiric factor replacement if hemophilia suspected; transfuse as needed; imaging as indicated |
| Suspected intracranial hemorrhage (altered consciousness, focal signs, bulging fontanelle) | EMERGENT | Immediate CT head; neurosurgery consultation; treat underlying coagulopathy urgently; do not delay imaging for laboratory results |
| Compartment syndrome (tense limb, severe pain, paresthesia) | EMERGENT | Urgent orthopedic/surgical consultation; fasciotomy may be required; factor replacement if bleeding disorder known |
| Widespread petechiae with fever | EMERGENT | Assume sepsis until proven otherwise; blood cultures; empiric antibiotics; urgent complete blood count; assess for meningococcemia, disseminated intravascular coagulation |
| Platelet count less than 10,000/microL with any bleeding | EMERGENT | Urgent hematology consultation; platelet transfusion if active bleeding; evaluate for leukemia; consider intravenous immunoglobulin if immune thrombocytopenia |
| Acute hemarthrosis (known or suspected hemophilia) | URGENT | Factor replacement within 2 hours of symptom onset; do not wait for laboratory confirmation if history suggestive; RICE (rest, ice, compression, elevation); hematology consultation |
| Platelet count 10,000-20,000/microL without significant bleeding | URGENT | Hematology consultation same day; blood film review; assess for secondary causes; consider treatment based on bleeding risk |
| New bruising in non-mobile infant | URGENT | Full bleeding workup AND safeguarding assessment; do not delay either evaluation; multidisciplinary approach |
| Pallor with hepatosplenomegaly and bruising | URGENT | Urgent complete blood count with differential and blood film; high suspicion for leukemia; same-day hematology/oncology referral if blasts present |
| Isolated thrombocytopenia in well child (platelet count 20,000-50,000/microL) | SOON (24-48 hours) | Outpatient hematology referral; activity restriction; bleeding precautions education; repeat complete blood count in 1-2 weeks if presumed immune thrombocytopenia |
| Easy bruising with normal platelet count, otherwise well | ROUTINE | Outpatient evaluation; detailed bleeding history; consider von Willebrand disease workup; elective hematology referral if bleeding score elevated |
Step 2: Classify the Bleeding Pattern
The pattern of bleeding helps narrow the differential diagnosis and guide investigation.
Mucocutaneous Bleeding Pattern
Suggests: Platelet disorder or von Willebrand disease
- Petechiae and superficial bruising
- Epistaxis
- Gingival bleeding
- Menorrhagia
- Prolonged bleeding from cuts
- Gastrointestinal bleeding
Initial workup: Complete blood count, blood film, von Willebrand panel, platelet function testing
Deep Tissue Bleeding Pattern
Suggests: Coagulation factor deficiency
- Hemarthrosis
- Deep muscle hematomas
- Intracranial hemorrhage
- Retroperitoneal bleeding
- Delayed post-surgical bleeding
- Large palpable hematomas
Initial workup: Complete blood count, prothrombin time, activated partial thromboplastin time, fibrinogen, factor assays
Step 3: Algorithm Based on Initial Laboratory Results
Algorithm A: Isolated Thrombocytopenia (Low Platelet Count, Normal PT and aPTT)
| Clinical Scenario | Most Likely Diagnosis | Next Steps |
|---|---|---|
| Well child, acute onset petechiae/bruising, recent viral illness, isolated thrombocytopenia, normal blood film otherwise | Immune thrombocytopenia (ITP) | Observation if platelet count greater than 20,000/microL and no significant bleeding; consider treatment if platelets less than 20,000/microL or significant mucosal bleeding; repeat complete blood count in 1-2 weeks |
| Unwell child, fever, hepatosplenomegaly, lymphadenopathy, abnormal cells on blood film | Leukemia or bone marrow infiltration | Urgent hematology/oncology referral; bone marrow aspirate; do not give steroids until leukemia excluded |
| Thrombocytopenia with microangiopathic hemolytic anemia (schistocytes, elevated lactate dehydrogenase, low haptoglobin) | Thrombotic microangiopathy (hemolytic uremic syndrome, thrombotic thrombocytopenic purpura) | Urgent nephrology and hematology consultation; assess renal function; do not transfuse platelets (may worsen); consider plasma exchange if thrombotic thrombocytopenic purpura |
| Neonate with thrombocytopenia, maternal history of immune thrombocytopenia or autoimmune disease | Neonatal alloimmune or autoimmune thrombocytopenia | Maternal platelet antibody testing; consider intravenous immunoglobulin; matched platelet transfusion if severe; cranial ultrasound to exclude intracranial hemorrhage |
| Thrombocytopenia with eczema, recurrent infections, small platelets | Wiskott-Aldrich syndrome | Genetic testing; immunology referral; consider bone marrow transplantation evaluation |
| Congenital thrombocytopenia with large platelets, hearing loss | MYH9-related disorder | Genetic testing; audiology evaluation; nephrology monitoring; usually mild bleeding tendency |
Algorithm B: Prolonged aPTT with Normal PT and Normal Platelet Count
| Clinical Scenario | Most Likely Diagnosis | Next Steps |
|---|---|---|
| Male child with hemarthrosis or deep muscle bleeding, family history of bleeding in males on maternal side | Hemophilia A or B | Factor VIII and Factor IX assays; mixing study (should correct); genetic testing for confirmation and carrier detection |
| Child with mucocutaneous bleeding, prolonged aPTT, family history of bleeding | Von Willebrand disease (with secondary Factor VIII reduction) | Von Willebrand factor antigen, von Willebrand factor activity (ristocetin cofactor), Factor VIII level; von Willebrand factor multimer analysis if type 2 suspected |
| Ashkenazi Jewish ancestry, variable bleeding tendency, prolonged aPTT | Factor XI deficiency (Hemophilia C) | Factor XI assay; note that bleeding severity does not correlate well with factor level |
| Prolonged aPTT, no bleeding history, aPTT does not correct with mixing study | Lupus anticoagulant (antiphospholipid antibody) | Mixing study; lupus anticoagulant testing; this is a prothrombotic state, not a bleeding disorder (despite prolonged aPTT) |
| Prolonged aPTT, no bleeding history, aPTT corrects with mixing study | Factor XII, prekallikrein, or high molecular weight kininogen deficiency | Specific factor assays; these do not cause clinical bleeding; safe for surgery |
Algorithm C: Prolonged PT with Normal aPTT and Normal Platelet Count
| Clinical Scenario | Most Likely Diagnosis | Next Steps |
|---|---|---|
| Neonate with bleeding, no vitamin K prophylaxis, breastfed | Vitamin K deficiency bleeding | Give vitamin K immediately (IV if severe bleeding); fresh frozen plasma if life-threatening; PT should normalize within hours of vitamin K |
| Child with malabsorption (celiac disease, cystic fibrosis, cholestatic liver disease) | Vitamin K deficiency (acquired) | Parenteral vitamin K (oral may not be absorbed); monitor PT response; treat underlying condition |
| Isolated prolonged PT, no clear cause, variable bleeding | Factor VII deficiency | Factor VII assay; rare autosomal recessive disorder; bleeding severity variable |
| Warfarin exposure (intentional or accidental) | Warfarin effect (or rodenticide poisoning) | Vitamin K; fresh frozen plasma if severe bleeding; consider superwarfarin (rodenticide) if prolonged effect |
Algorithm D: Both PT and aPTT Prolonged
| Clinical Scenario | Most Likely Diagnosis | Next Steps |
|---|---|---|
| Sick child, sepsis, shock, multiple organ dysfunction, thrombocytopenia, elevated D-dimer, low fibrinogen | Disseminated intravascular coagulation | Treat underlying cause; supportive blood product replacement; platelet and fresh frozen plasma transfusion if bleeding |
| Child with liver disease, jaundice, hepatomegaly | Liver failure/hepatic coagulopathy | Assess liver function; vitamin K trial (may help if cholestasis); Factor V level helps distinguish (low in liver failure, normal in vitamin K deficiency) |
| Severe bleeding, undetectable fibrinogen, prolonged thrombin time | Afibrinogenemia or severe hypofibrinogenemia | Fibrinogen level; cryoprecipitate or fibrinogen concentrate replacement; rare autosomal recessive condition |
| Rare combined factor deficiencies, consanguineous family | Combined Factor V and VIII deficiency, or other rare combined deficiencies | Individual factor assays; genetic testing; very rare autosomal recessive conditions |
Algorithm E: Normal PT, aPTT, and Platelet Count with Significant Bleeding History
| Clinical Scenario | Most Likely Diagnosis | Next Steps |
|---|---|---|
| Mucocutaneous bleeding, family history, menorrhagia | Von Willebrand disease (mild, with normal aPTT) | Von Willebrand factor antigen and activity; may need repeat testing (levels fluctuate with stress, illness, estrogen) |
| Mucocutaneous bleeding, normal platelet count, abnormal platelet aggregation studies | Platelet function disorder | Platelet function analyzer (PFA-100); platelet aggregation studies; flow cytometry for surface glycoproteins |
| Delayed bleeding, umbilical stump bleeding, poor wound healing | Factor XIII deficiency | Factor XIII activity assay (NOT detected by PT or aPTT); clot solubility test as screening |
| Delayed bleeding after initial hemostasis, excessive fibrinolysis | Alpha-2-antiplasmin deficiency or plasminogen activator inhibitor-1 deficiency | Specific assays for fibrinolytic pathway components; rare disorders |
| Easy bruising, hypermobile joints, skin hyperextensibility | Connective tissue disorder (Ehlers-Danlos syndrome) | Clinical assessment (Beighton score); genetic testing for specific subtypes; cardiology evaluation for vascular type |
| Child with significant bleeding history but completely normal comprehensive workup | Bleeding disorder of unknown cause (or no bleeding disorder) | Consider re-evaluation at specialized hemostasis center; global hemostatic assays (thrombin generation); some patients have mild undetectable disorders; empiric desmopressin trial before procedures |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Child needs urgent surgery but has undiagnosed bleeding symptoms | Complete blood count, PT, aPTT, fibrinogen STAT; document bleeding history; discuss with hematology | If tests normal and history not strongly suggestive, may proceed with caution; if tests abnormal or strong history, delay if possible and complete workup; have blood products available |
| Known hemophilia patient with acute joint swelling | Give factor replacement immediately (do not wait for imaging or laboratory confirmation); RICE protocol | Contact hemophilia treatment center; assess for inhibitor if poor response; physical therapy once acute phase resolved |
| Child with immune thrombocytopenia and head trauma | Urgent CT head; consider platelet transfusion and intravenous immunoglobulin regardless of platelet count given mechanism | Neurosurgery consultation if intracranial hemorrhage; close observation; aim to raise platelets acutely |
| Suspected bleeding disorder but family requesting circumcision for newborn | Complete workup first; counsel family about bleeding risk | If workup confirms bleeding disorder, circumcision requires factor replacement and specialist input; if workup negative, may proceed with normal precautions |
| Adolescent female with menorrhagia and suspected bleeding disorder | Complete blood count (assess for iron deficiency anemia); von Willebrand panel; consider gynecology referral | If von Willebrand disease confirmed, trial of desmopressin at next menses; hormonal therapy; tranexamic acid; iron supplementation if deficient |
| Laboratory results suggest bleeding disorder but child has no bleeding history | Repeat testing to confirm; review sample collection and handling | If confirmed, may be mild disorder not yet challenged; counsel family about precautions before surgery; some abnormalities (Factor XII deficiency, lupus anticoagulant) do not cause bleeding |
| Strong family history but child’s workup is normal | Ensure comprehensive testing including von Willebrand factor (may need repeated testing) and platelet function | Some disorders are not detectable with standard tests; consider Factor XIII, fibrinolytic pathway; refer to specialized center; empiric precautions before procedures may be warranted |
| Incidental finding of prolonged aPTT in well child before routine surgery | Detailed bleeding history; mixing study to differentiate factor deficiency from inhibitor | If mixing study corrects and no bleeding history, likely Factor XII/contact factor deficiency (no bleeding risk); if does not correct, may be lupus anticoagulant (thrombosis risk, not bleeding); can proceed with surgery if no clinical bleeding concerns |
When to Refer to Pediatric Hematology
Urgent Referral (Same Day)
- Suspected or confirmed leukemia
- Severe thrombocytopenia (less than 20,000/microL)
- Active significant bleeding with abnormal coagulation
- Suspected hemophilia with acute bleeding
- Disseminated intravascular coagulation
- Thrombotic microangiopathy
- Unexplained pancytopenia
Routine Referral (Within 2-4 Weeks)
- Elevated bleeding score with normal initial workup
- Confirmed or suspected von Willebrand disease
- Abnormal platelet function studies
- Family history of bleeding disorder requiring evaluation
- Chronic immune thrombocytopenia (greater than 12 months)
- Pre-operative evaluation of child with bleeding history
- Need for specialized testing not available locally
Troubleshooting: Evaluation Not Yielding Diagnosis
Ask These Questions When Workup is Unrevealing
- Was the bleeding history truly significant? Re-evaluate using standardized bleeding score; many referred children have normal childhood bruising
- Were samples collected and processed correctly? Hemostasis samples are time-sensitive; repeat if any concern about sample quality
- Was von Willebrand testing performed under optimal conditions? Levels can be falsely normal during acute illness, stress, or with estrogen; repeat when patient is well
- Were platelet function tests performed? Platelet aggregation studies require specialized laboratory and fresh samples
- Was Factor XIII tested? Not detected by PT or aPTT; requires specific assay
- Were fibrinolytic pathway defects considered? Alpha-2-antiplasmin and plasminogen activator inhibitor-1 deficiency are rare but cause real bleeding
- Is this a connective tissue disorder rather than hemostatic defect? Assess for hypermobility, skin changes
- Should the patient be referred to a specialized hemostasis center? Advanced testing including thrombin generation assays may be diagnostic
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
Pattern predicts pathology: Mucocutaneous bleeding (petechiae, epistaxis, gingival bleeding, menorrhagia) suggests platelet or von Willebrand factor disorders. Deep tissue bleeding (hemarthrosis, muscle hematomas) suggests coagulation factor deficiency. This pattern recognition guides both clinical suspicion and laboratory testing.
History is the most powerful diagnostic tool: A detailed, structured bleeding history using a validated bleeding score is more predictive of bleeding disorders than laboratory tests alone. Many children with mild bleeding disorders have normal screening tests.
Immune thrombocytopenia is a diagnosis of exclusion in children: The classic presentation is a well child with acute onset of petechiae and bruising following a viral illness, with isolated thrombocytopenia and an otherwise normal blood film. Any atypical features (unwell child, hepatosplenomegaly, lymphadenopathy, other cytopenias, abnormal cells) require further investigation before assuming immune thrombocytopenia.
Von Willebrand disease is commonly underdiagnosed: It is the most common inherited bleeding disorder and should be considered in any child with mucocutaneous bleeding, menorrhagia, or bleeding after dental or surgical procedures. Levels can fluctuate, so repeat testing may be needed, and testing during acute illness or stress may give falsely normal results.
Normal PT and aPTT do not exclude all bleeding disorders: Factor XIII deficiency, mild von Willebrand disease, platelet function disorders, and fibrinolytic pathway defects can all present with significant bleeding and completely normal PT and aPTT. If clinical suspicion is high, pursue additional testing.
Treat hemophilia first, diagnose later: In a child with suspected hemophilia presenting with acute bleeding (especially joint or muscle bleeding), give factor replacement immediately. Do not delay treatment waiting for laboratory confirmation. The risk of permanent joint damage or life-threatening bleeding far outweighs the cost of empiric treatment.
Consider child protection alongside bleeding evaluation: Bruising in unusual locations, in non-mobile infants, or with inconsistent history requires dual consideration of bleeding disorders and non-accidental injury. These are not mutually exclusive — children with bleeding disorders can also be abused. Both evaluations should proceed simultaneously.
Menorrhagia may be the first presentation of a bleeding disorder: Up to 20% of adolescents with menorrhagia have an underlying bleeding disorder, most commonly von Willebrand disease. Any adolescent presenting with heavy menstrual bleeding should have a bleeding history taken and, if suggestive, a hemostatic workup performed.
Critical Pitfalls to Avoid
Do not give steroids for presumed immune thrombocytopenia without excluding leukemia: Steroids can induce temporary remission in leukemia, delaying diagnosis and worsening prognosis. Always review the blood film carefully and consider bone marrow examination if there are any atypical features (other cytopenias, abnormal cells, hepatosplenomegaly, lymphadenopathy, bone pain).
Do not attribute bruising in non-mobile infants to minor trauma: Infants who are not yet rolling, crawling, or walking should not have bruises. Any bruising in this age group requires immediate investigation for both bleeding disorders and non-accidental injury. “He must have bumped himself” is not an acceptable explanation.
Do not assume a normal aPTT excludes hemophilia: Mild hemophilia (Factor VIII or IX levels 5-40%) may have a normal or only slightly prolonged aPTT. If the clinical history suggests hemophilia (deep tissue bleeding, hemarthrosis, family history), perform specific factor assays regardless of screening test results.
Do not forget Factor XIII deficiency: Factor XIII is the most commonly missed severe bleeding disorder because PT and aPTT are completely normal. The classic presentation is umbilical stump bleeding, delayed wound healing, and intracranial hemorrhage. Always consider Factor XIII deficiency when there is a strong bleeding history with normal routine coagulation tests.
Do not transfuse platelets in thrombotic thrombocytopenic purpura or hemolytic uremic syndrome: In thrombotic microangiopathies, platelet transfusion can worsen the condition by fueling microvascular thrombosis. These conditions require specific treatment (plasma exchange for thrombotic thrombocytopenic purpura, supportive care for typical hemolytic uremic syndrome). Look for the hallmarks: microangiopathic hemolytic anemia with schistocytes, thrombocytopenia, and organ dysfunction.
Do not interpret a prolonged aPTT that does not correct on mixing as a bleeding risk: Lupus anticoagulant (antiphospholipid antibody) prolongs aPTT and does not correct with mixing, but it is a prothrombotic condition, not a bleeding disorder. These patients are at risk for thrombosis, not hemorrhage, and can safely undergo surgery.
Do not delay imaging for coagulation results in suspected intracranial hemorrhage: If a child has signs or symptoms of intracranial hemorrhage, obtain CT imaging immediately. Treatment of any coagulopathy can be given concurrently, but the urgency of diagnosing and treating intracranial bleeding takes priority over awaiting laboratory confirmation of a bleeding disorder.
Do not order von Willebrand testing during acute illness or stress: Von Willebrand factor is an acute phase reactant and levels rise with illness, stress, inflammation, and estrogen. Testing during these conditions may give falsely normal results. Test when the patient is well, and consider repeat testing if initial results are borderline or inconsistent with clinical suspicion.
Key Takeaways
- Most children referred for easy bruising have normal childhood bruising or mild findings that do not indicate a significant bleeding disorder — use a standardized bleeding score to distinguish normal from pathological.
- The pattern of bleeding (mucocutaneous versus deep tissue) is the most important clinical clue to the underlying cause and should guide the direction of laboratory investigation.
- Immune thrombocytopenia is the most common cause of acute thrombocytopenia in childhood — it presents in a well child with isolated low platelets and is usually self-limiting, but leukemia must be excluded before treatment with steroids.
- Von Willebrand disease is the most common inherited bleeding disorder and is frequently underdiagnosed — consider it in any patient with mucocutaneous bleeding, menorrhagia, or post-procedural bleeding.
- Hemophilia should be treated empirically when suspected in the setting of acute bleeding — do not wait for laboratory confirmation to give factor replacement.
- Normal PT and aPTT do not exclude all bleeding disorders — Factor XIII deficiency, mild von Willebrand disease, and platelet function disorders can all present with normal screening tests.
- Bruising in non-mobile infants is always concerning — both bleeding disorders and non-accidental injury must be considered, and these evaluations should proceed in parallel.
- Family history is critically important — take a three-generation pedigree and ask about bleeding symptoms (not just diagnosed disorders) in relatives.
- Age-specific considerations matter — neonates have physiologically different coagulation parameters, and reference ranges must be age-appropriate.
- When in doubt, consult pediatric hematology — early specialist input can guide evaluation, prevent missed diagnoses, and ensure appropriate management before procedures.
Quick Reference Algorithm
Systematic Approach to Easy Bruising and Bleeding in Children:
- Assess urgency: Is there active life-threatening bleeding, signs of intracranial hemorrhage, or hemodynamic instability? If yes, resuscitate and treat empirically while obtaining urgent consultation.
- Take a detailed bleeding history: Use the “BLEEDS” mnemonic and calculate a bleeding score. Determine if the bleeding pattern is mucocutaneous (suggests platelet/von Willebrand factor problem) or deep tissue (suggests factor deficiency).
- Perform a complete physical examination: Document all bruises and skin findings. Assess for hepatosplenomegaly, lymphadenopathy, joint swelling, and signs of systemic illness. Evaluate for non-accidental injury if bruise pattern or history is concerning.
- Order initial laboratory tests: Complete blood count with blood film review, prothrombin time, activated partial thromboplastin time, and fibrinogen. Consider von Willebrand panel if mucocutaneous bleeding pattern.
- Interpret results systematically: Use the laboratory-based algorithms (isolated thrombocytopenia, prolonged aPTT, prolonged PT, both prolonged, or all normal) to narrow the differential and guide further testing.
- Order targeted confirmatory tests: Based on clinical suspicion and screening results — factor assays, von Willebrand studies, platelet function testing, Factor XIII assay as indicated.
- Manage according to diagnosis: Treatment varies widely from observation (mild immune thrombocytopenia) to lifelong factor replacement (severe hemophilia). Involve pediatric hematology for confirmed bleeding disorders.
- Provide anticipatory guidance: Educate families about activity restrictions, medication avoidance (no aspirin or NSAIDs without guidance), when to seek care, and medical alert identification for significant disorders.
Summary Decision Tree
| Initial Finding | Next Consideration | Key Actions |
|---|---|---|
| Petechiae and purpura in well child | Likely immune thrombocytopenia if isolated thrombocytopenia | Confirm isolated thrombocytopenia; review film; exclude leukemia; observe or treat based on severity |
| Hemarthrosis or deep muscle hematoma | Likely hemophilia | Give factor replacement immediately; do not wait for results; obtain Factor VIII and IX levels |
| Mucocutaneous bleeding, family history, menorrhagia | Likely von Willebrand disease | Obtain von Willebrand panel when patient is well; may need repeat testing |
| Bleeding neonate, no vitamin K given | Likely vitamin K deficiency bleeding | Give vitamin K immediately; fresh frozen plasma if life-threatening bleeding |
| Bruising in non-mobile infant | Bleeding disorder OR non-accidental injury | Full bleeding workup AND safeguarding assessment simultaneously |
| Bruising with pallor, hepatosplenomegaly, lymphadenopathy | Likely leukemia or marrow infiltration | Urgent complete blood count with film; same-day hematology/oncology referral if blasts seen |
| Strong bleeding history but all tests normal | Consider Factor XIII deficiency, platelet function disorder, connective tissue disorder | Order Factor XIII assay; platelet function studies; assess for hypermobility; refer to specialist center |